FindTrial
Sign In

Clinical Evaluation of Kamala Arka and Taruni Arka in Hyperpigmentation

Comparative Clinical Study of Kamala Arka and Taruni Arka in Hyperpigmentation - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078831
Enrollment
40
Registered
2024-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

J S Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs of hyperpigmentation (dark patches) on face fulfilling the diagnosis will be included

Exclusion criteria

Exclusion criteria: 1.Patients having any other diseases like AIDS, STD, itching, wound, active acne, burning, eczema, dermatitis and other disorders which lead to fatal condition for the patients. 2.Birth marks and moles will be excluded. 3.Pregnant and lactating women. 4.Patients who are on corticosteroid drugs or immune-suppressants and past history of steroidal use in the last 6 months. 5.Other concomitant skin disease occurring with allergic reaction of any other disease.

Design outcomes

Primary

MeasureTime frame
Changes in signs of hyperpigmentationTimepoint: 12 weeks—

Secondary

MeasureTime frame
Difference in clinical efficacy of Kamala Arka and Taruni ArkaTimepoint: 12 weeks—

Countries

India

Contacts

Public ContactProf Dr Vidhi Bapna

J. S. Ayurved Mahavidyalaya

drkumathvidhi29@yahoo.com9428972618

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026